| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 14.099 | 10.502 | 10.249 | 5.629 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Income - EUR | 14.099 | 10.502 | 10.249 | 5.629 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Expenses - EUR | 6.299 | 10.237 | 4.349 | 5.035 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit/Loss - EUR | 7.799 | 265 | 5.900 | 594 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Profit/Loss - EUR | 7.376 | 97 | 5.592 | 425 | 0 | 0 | 0 | 0 | 0 | 0 |
| Employees | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Biobi Medical Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | 24.547 | 544 | 6.056 | 6.306 | 1.969 | 59 | 57 | 58 | 57 | 57 |
| Inventories | 97 | 0 | 151 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 949 | 0 | 0 | 13 | 13 | 0 | 0 | 0 | 0 | 0 |
| Cash | 23.501 | 544 | 5.905 | 6.293 | 1.956 | 59 | 57 | 58 | 57 | 57 |
| Shareholders Funds | 24.073 | 544 | 5.991 | 6.306 | 1.969 | 59 | 57 | 58 | 57 | 57 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 474 | 0 | 66 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8610 - 8610" | |||||||||
| CAEN Financial Year |
8610
|
|||||||||
Comments - Biobi Medical Srl